WORKING GROUP NAME: Safety

CO-CHAIRS:

Robin Christensen:

robin.christensen@regionh.dk

Lee Simon:

lssconsult@aol.com

Peter Brooks:

brooksp@unimelb.edu.au

RECENT PUBLICATIONS

OMERACT 14

Improving benefit-harm assessment of therapies from the patient perspectives: OMERACT pre-meeting towards consensus on core sets for randomized controlled trials

Patient Perspectives on DMARD Safety Concerns in Rheumatology Trials: Results from Inflammatory Arthritis Patient Focus Groups and OMERACT Attendee Discussions

Identifying Possible Outcome Domains from Existing Outcome Measures to Inform an OMERACT Core Domain Set for Safety in Rheumatology Trials

OMERACT 13

Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working Group

MEMBERSHIP:

  • Maarten Boers
  • Peter Brooks
  • Robin Christensen
  • Daniel Devoe
  • Daniel Furst
  • Niti Goel
  • Susan Goodman
  • David Henry
  • Catherine Hill
  • Louise Klokker
  • Amye Leong
  • Sarah Mackie
  • Pam Richards
  • Marieke Scholte-Voshaar
  • Lee Simon
  • Vibeke Strand
  • Maria Suarez-Almazor
  • Caroline Terwee
  • Peter Tugwell
  • Paula Williamson
  • Thasia Woodworth